SCHEMBL6414729

SCHEMBL6414729

CCOC(=O)NC(CCN1CCC2(CC1)CCN(Cc1ccc(OC)cc1)C2=O)c1ccccn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.41
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
POLB P06746 1/20 0.40
ALDH1A1 P00352 2/20 0.39
MMP1 P03956 2/20 0.39
MMP9 P14780 2/20 0.39
MMP13 P45452 2/20 0.39
ADAM17 P78536 1/20 0.39
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38
TSHR P16473 1/20 0.38
CACNA1G O43497 1/20 0.38
DRD2 P14416 3/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
LMNA P02545 1/20 0.36
MMP2 P08253 1/20 0.36
MMP3 P08254 1/20 0.36
MMP8 P22894 1/20 0.36
MMP14 P50281 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6414722 0.99 SMN1; SMN2 (0.41) SMN1; SMN2MEN1KMT2APOLBALDH1A1
SCHEMBL6417350 0.92 DRD2 (0.36) POLBALDH1A1DRD2EGLN1
Hydrochloric Acid SCHEMBL6417345 0.91 DRD2 (0.36) ALDH1A1OPRD1DRD2EGLN1
SCHEMBL6409117 0.90 SMN1; SMN2 (0.42) SMN1; SMN2MEN1KMT2AALDH1A1MMP1
Hydrochloric Acid SCHEMBL6408867 0.90 SMN1; SMN2 (0.41) SMN1; SMN2MEN1KMT2AALDH1A1MMP1
Hydrochloric Acid SCHEMBL6411257 0.88 SMN1; SMN2 (0.41) SMN1; SMN2ALDH1A1MMP1MMP9MMP13
Hydrochloric Acid SCHEMBL6409342 0.88 SMN1; SMN2 (0.41) SMN1; SMN2MEN1KMT2APOLBALDH1A1
SCHEMBL6411851 0.87 MEN1 (0.42) SMN1; SMN2MEN1KMT2APOLBALDH1A1
SCHEMBL6414737 0.87 CCR5 (0.41) MEN1KMT2APOLBALDH1A1MMP1
SCHEMBL6410779 0.87 KMT2A (0.42) MEN1KMT2APOLBALDH1A1MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050075326-A1 Spiro compounds and methods for the modulation of chemokine receptor activity VIROCHEM PHARMA INC (CA) 2005-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075326-A1 Spiro compounds and methods for the modulation of chemokine receptor activity CXCR1, CXCR4, CXCR2 SMN1; SMN2 4429/4885MEN1 4007/4885KMT2A 4587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.